Usefulness of tests to measure platelet function

被引:14
作者
Breddin, HK
Harder, S
机构
[1] Int Inst Thrombosis & Vasc Dis eV, D-60598 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Inst Klin Pharmakol, D-6000 Frankfurt, Germany
来源
VASA-JOURNAL OF VASCULAR DISEASES | 2003年 / 32卷 / 03期
关键词
platelet function; thrombelastography; aggregation; diabetes mellitus;
D O I
10.1024/0301-1526.32.3.123
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Usefulness of tests to measure platelet function Platelet function tests are used to detect patients with abormal platelet function, which may be inborn or acquired or to detect increased platelet activation which may be accompanied by an increased risk of thrombosis. Platelet function tests are also used to monitor platelet function inhibitors as aspirin, clopidogrel or platelet membrane glycoprotein Iib/IIIa-inhibitors. Incorrect blood sampling is a major source of error in measuring platelet function. Global tests besides platelet count and bleeding time are thrombelastography, the platelet function analyzer (PFA) and possibly in the future the new Impact(R) -system. Specific tests measure platelet spreading and adhesion to defined surfaces. hi a series methods platelets are counted before and after passage of filter Some of these tests are partially standardized. a The most frequently measured platelet function is aggregation induced by ADP collagen or other substances as first described by Gustav Born. Some newer methods to perform aggregometry are described. Platelet activation can be detected by measuring spontaneous aggregation as ill the PAT-test. Prospective trials with this test have shown that enhanced spontaneous aggregation is a risk factor for new, vascular occlusions in diabetics and for myocardial infarctions in healthy individuals. The Wu and Hoak-test and the measurement of released platelet factor 4 or betaglobulin are of limited value. Flow cytometric methods are frequently used to measure platelet activation markers as CD 62 and others. Platelet induced thrombin generation is all interesting function to measure drug effects. None of the presently available platelet function tests is well standardized, so there is much room for improvement.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 47 条
  • [1] Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial
    Ault, KA
    Cannon, CP
    Mitchell, J
    McCahan, J
    Tracy, RP
    Novotny, WF
    Reimann, JD
    Braunwald, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) : 634 - 639
  • [2] AULT KA, 1997, LAB HEMATOL, V3, P125
  • [3] Basic-Micic M, 1991, HAMOSTASEOLOGIE, V11, P114
  • [4] BASICMICIC M, 1992, HAEMOSTASIS, V22, P309
  • [5] BORN GVR, 1962, J PHYSIOL-LONDON, V162, pP67
  • [6] BOWRY SK, 1985, THROMB HAEMOSTASIS, V53, P381
  • [7] Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study
    Breddin, HK
    Lippold, R
    Bittner, M
    Kirchmaier, CM
    Krzywanek, HJ
    Michaelis, J
    [J]. ATHEROSCLEROSIS, 1999, 144 (01) : 211 - 219
  • [8] BREDDIN HK, 1986, INT ANGIOL, V5, P181
  • [9] BREDDIN HK, 1976, THROMB HAEMOSTASIS, V35, P302
  • [10] ZUR MESSUNG DER THROMBOZYTENADHASIVITAT
    BREDDIN, K
    [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1964, 12 (1-2): : 269 - +